Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment.
Terzi M, Helvacı EM, Şen S, Boz C, Çilingir V, Akçalı A, Beckmann Y, Uzunköprü C, Türkoğlu R, Yüceyar N, Efendi H, Bünül SD, Seferoğlu M, Kotan D, Güler S, Balcı BP, Öztürk B, Mungan S, İçen NK, Ömerhoca S, Yurtoğulları Ş, Sevim S, Türkoğlu ŞA, Çam M, Yetkin MF, Yoldaş TK, Sıvacı AÖ, Gökçe ŞF, Gürsoy E, Ünal A, Bilge N, Ağan K, Toprak MK, Koçer B, Sezer G, Terzi Y. Terzi M, et al. Among authors: yurtogullari s. Noro Psikiyatr Ars. 2023 Jan 13;60(1):23-27. doi: 10.29399/npa.28081. eCollection 2023. Noro Psikiyatr Ars. 2023. PMID: 36911568 Free PMC article.
Sporadic Creutzfeldt-Jacob Disease: An 8-Year Experience from a Single Center in Turkey.
Taşkapilioğlu Ö, Seferoğlu M, Yurtoğullari Ş, Hakyemez B, Erer S, Karli N, Bakar M, Turan ÖF, Zarifoğlu M, Tolunay Ş, Bora İ. Taşkapilioğlu Ö, et al. Among authors: yurtogullari s. Noro Psikiyatr Ars. 2013 Dec;50(4):306-311. doi: 10.4274/Npa.y5903. Epub 2013 Dec 1. Noro Psikiyatr Ars. 2013. PMID: 28360562 Free PMC article.
Erratum: Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment.
Terzi M, Helvacı EM, Şen S, Boz C, Çilingir V, Akçalı A, Beckmann Y, Uzunköprü C, Türkoğlu R, Yüceyar N, Efendi H, Destan Bünül S, Seferoğlu M, Kotan D, Güler S, Balcı BP, Öztürk B, Mungan S, İçen NK, Ömerhoca S, Yurtoğulları Ş, Sevim S, Türkoğlu ŞA, Çam M, Yetkin MF, Yoldaş TK, Sıvacı AÖ, Gökçe ŞF, Gürsoy E, Ünal A, Bilge N, Ağan K, Toprak MK, Koçer B, Sözer G, Terzi Y. Terzi M, et al. Among authors: yurtogullari s. Noro Psikiyatr Ars. 2023 May 25;60(2):190. doi: 10.29399/npa.28499. eCollection 2023. Noro Psikiyatr Ars. 2023. PMID: 37287556 Free PMC article.
Exploring the impact of wearing-off phenomenon in ocrelizumab-treated multiple sclerosis patients: Insights from a comprehensive study.
Seferoğlu M, Tunç A, Sıvacı AÖ, Uzuner GT, Mungan S, İnanç Y, Yetkin MF, Öztürk B, Koç ER, Türkoğlu ŞA, Aksoy S, Yurtoğulları Ş, Elçi Ö. Seferoğlu M, et al. Among authors: yurtogullari s. Mult Scler Relat Disord. 2024 Dec;92:105939. doi: 10.1016/j.msard.2024.105939. Epub 2024 Oct 11. Mult Scler Relat Disord. 2024. PMID: 39423725